PPARG and Hepatic fibrosis: Similarly, Bae and colleagues demonstrated in HSC-T6 cells that the PPARγ agonist KR62776 administration caused HSC apoptosis, accompanied by a time- and concentration-dependent decrease in the alpha-smooth muscle actin levels, showing that PPARγ stimulation is strictly involved in limiting the activation and proliferation of HSC preventing liver fibrosis [71].